The India Supreme Court’s rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world’s largest drugmakers.
Business Headlines
Business Headlines
India"s rejection of drug patent could reverberate
No comments:
Post a Comment